Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
European Heart Journal. Case Reports
|
March 19, 2021
Progression of electrocardiogram changes in an untreated fabry disease: a case report
Isabel Mattig, Sima Canaan-Kühl, Christoph Tillmanns, et al.
Clinical Kidney Journal
|
October 6, 2017
Late-onset Bartter syndrome type II
Benjamin Gollasch, Yoland-Marie Anistan, Sima Canaan-Kühl, et al.
Journal of Immunological Methods
|
May 27, 2008
Detection and characterization of antibodies against recombinant human erythropoietin by RIPA, ELISA and neutralization assay in patients with renal anemia
Johann Gross, Renate Moller, Steffen Bischoff, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
May 25, 2026
Tolerability of SGLT2 inhibitors in patients with Fabry disease: An observational study
Isabel Mattig, Berit Zirkelbach, Carina Bonnekoh, et al.
The International Journal of Cardiovascular Imaging
|
October 16, 2014
Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status
Daniel A Morris, Daniela Blaschke, Sima Canaan-Kühl, et al.
Echocardiography (Mount Kisco, N.Y.)
|
October 21, 2021
Comparative analysis of phasic left atrial strain and left ventricular posterolateral strain pattern to discriminate Fabry cardiomyopathy from other forms of left ventricular hypertrophy
David Frumkin, Isabel Mattig, Nina Laule, et al.
Frontiers in Neuroscience
|
July 3, 2020
Bridging the Gap Between Vessels and Nerves in Fabry Disease
Julia Forstenpointner, Manon Sendel, Paul Moeller, et al.
Journal of Medical Genetics
|
June 12, 2020
Treatment switch in Fabry disease- a matter of dose?
Malte Lenders, Peter Nordbeck, Sima Canaan-Kühl, et al.
Neurological Research and Practice
|
December 16, 2025
Impact of migalastat on cerebral outcomes in fabry disease - results from the prospective observational FAMOUS trial
Momoko Choudhury, Malte Lenders, Pauline Laufer, et al.
Diagnostics (Basel, Switzerland)
|
December 3, 2020
Assessment of Peripheral Nervous System Alterations in Patients with the Fabry Related <i>GLA</i>-Variant p.A143T
Tim Godel, Katharina V Cossel, Reinhard E Friedrich, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
European Heart Journal. Case Reports
|
March 19, 2021
Progression of electrocardiogram changes in an untreated fabry disease: a case report
Isabel Mattig, Sima Canaan-Kühl, Christoph Tillmanns, et al.
Clinical Kidney Journal
|
October 6, 2017
Late-onset Bartter syndrome type II
Benjamin Gollasch, Yoland-Marie Anistan, Sima Canaan-Kühl, et al.
Journal of Immunological Methods
|
May 27, 2008
Detection and characterization of antibodies against recombinant human erythropoietin by RIPA, ELISA and neutralization assay in patients with renal anemia
Johann Gross, Renate Moller, Steffen Bischoff, et al.
American Heart Journal Plus : Cardiology Research and Practice
|
May 25, 2026
Tolerability of SGLT2 inhibitors in patients with Fabry disease: An observational study
Isabel Mattig, Berit Zirkelbach, Carina Bonnekoh, et al.
The International Journal of Cardiovascular Imaging
|
October 16, 2014
Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status
Daniel A Morris, Daniela Blaschke, Sima Canaan-Kühl, et al.
Echocardiography (Mount Kisco, N.Y.)
|
October 21, 2021
Comparative analysis of phasic left atrial strain and left ventricular posterolateral strain pattern to discriminate Fabry cardiomyopathy from other forms of left ventricular hypertrophy
David Frumkin, Isabel Mattig, Nina Laule, et al.
Frontiers in Neuroscience
|
July 3, 2020
Bridging the Gap Between Vessels and Nerves in Fabry Disease
Julia Forstenpointner, Manon Sendel, Paul Moeller, et al.
Journal of Medical Genetics
|
June 12, 2020
Treatment switch in Fabry disease- a matter of dose?
Malte Lenders, Peter Nordbeck, Sima Canaan-Kühl, et al.
Neurological Research and Practice
|
December 16, 2025
Impact of migalastat on cerebral outcomes in fabry disease - results from the prospective observational FAMOUS trial
Momoko Choudhury, Malte Lenders, Pauline Laufer, et al.
Diagnostics (Basel, Switzerland)
|
December 3, 2020
Assessment of Peripheral Nervous System Alterations in Patients with the Fabry Related <i>GLA</i>-Variant p.A143T
Tim Godel, Katharina V Cossel, Reinhard E Friedrich, et al.
Page
of 3